Home » Stocks » INGN

Inogen, Inc. (INGN)

Stock Price: $53.14 USD 0.65 (1.24%)
Updated Mar 1, 2021 4:00 PM EST - Market closed
Market Cap 1.18B
Revenue (ttm) 308.49M
Net Income (ttm) -5.83M
Shares Out 21.98M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 1
Last Price $53.14
Previous Close $52.49
Change ($) 0.65
Change (%) 1.24%
Day's Open 53.84
Day's Range 51.50 - 53.77
Day's Volume 180,456
52-Week Range 26.57 - 56.46

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 4 days ago

Inogen's (INGN) fourth-quarter results benefit from higher rental revenues and strength in business-to-business revenues.

Zacks Investment Research - 5 days ago

Inogen (INGN) delivered earnings and revenue surprises of 17.86% and 6.92%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 5 days ago

Shares of Inogen (NASDAQ:INGN) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 483.33% year over year to ($0.23), which beat ...

Business Wire - 5 days ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial re...

Benzinga - 6 days ago

Inogen (NASDAQ:INGN) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.

Zacks Investment Research - 1 week ago

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 1 week ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kriste...

Business Wire - 2 weeks ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Co...

Business Wire - 2 weeks ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will rele...

Business Wire - 1 month ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Bo...

Business Wire - 2 months ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Co...

Zacks Investment Research - 2 months ago

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

Business Wire - 3 months ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Co...

Zacks Investment Research - 3 months ago

Inogen (INGN) saw revenue decline within its Sales segment in Q3

Seeking Alpha - 3 months ago

Inogen Inc. (INGN) CEO Scott Wilkinson on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha - 3 months ago

Inogen Inc (INGN) CEO Scott Wilkinson on Q2 2020 Results - Quick Version Earnings Call Transcript

Zacks Investment Research - 3 months ago

Inogen (INGN) delivered earnings and revenue surprises of -300.00% and -0.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 3 months ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial re...

Zacks Investment Research - 4 months ago

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 4 months ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will rele...

Zacks Investment Research - 5 months ago

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 6 months ago

Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects

Zacks Investment Research - 6 months ago

Inogen (INGN) saw growth in revenues within its Rental segment in Q2.

Seeking Alpha - 6 months ago

Inogen Inc (INGN) CEO Scott Wilkinson on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 6 months ago

Inogen (INGN) delivered earnings and revenue surprises of 250.00% and -10.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 6 months ago

Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results.

Business Wire - 6 months ago

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc.

Seeking Alpha - 7 months ago

Inogen has been a real boom and bust story in terms of its stock price in recent years.

Zacks Investment Research - 7 months ago

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 7 months ago

Inogen: Backdoor Bet On Travel

Zacks Investment Research - 8 months ago

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 9 months ago

Inogen (INGN) reported growth in business-to-business international and domestic revenues in Q1.

Seeking Alpha - 9 months ago

Inogen, Inc. (INGN) CEO Scott Wilkinson on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

Inogen (INGN) delivered earnings and revenue surprises of 36.36% and 6.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 10 months ago

Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects.

Zacks Investment Research - 10 months ago

Oxygen therapy has emerged as a necessity for COVID-19 patients.

Other stocks mentioned: IVC, VAPO
Zacks Investment Research - 11 months ago

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 11 months ago

Inogen (INGN) expects to report a loss per share in the first quarter of 2020.

Zacks Investment Research - 1 year ago

Inogen (INGN) sees segmental softness in the fourth quarter.

Seeking Alpha - 1 year ago

Inogen, Inc. (INGN) CEO Scott Wilkinson on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Inogen (INGN) delivered earnings and revenue surprises of -36.36% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Inogen, Inc. (INGN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

The Motley Fool - 1 year ago

Big declines in stock price may bring big opportunities for patient investors.

Other stocks mentioned: I, X
Zacks Investment Research - 1 year ago

Inogen (INGN) expects direct-to-consumer sales to be its fastest-growing channel in 2020.

Zacks Investment Research - 1 year ago

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 1 year ago

Inogen: Solid Bet For End Of 2019

Zacks Investment Research - 1 year ago

Softness in domestic and international business-to-business revenues impact Inogen's (INGN) Q3 results.

Seeking Alpha - 1 year ago

Inogen, Inc. (INGN) CEO Scott Wilkinson on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Inogen (INGN) delivered earnings and revenue surprises of 34.78% and 0.42%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

About INGN

Inogen, a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen conce... [Read more...]

Industry
Medical Devices
IPO Date
Feb 14, 2014
CEO
Scott Wilkinson
Employees
938
Stock Exchange
NASDAQ
Ticker Symbol
INGN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Inogen stock is "Hold." The 12-month stock price forecast is 54.33, which is an increase of 2.24% from the latest price.

Price Target
$54.33
(2.24% upside)
Analyst Consensus: Hold